Skyrocketing specialty drug cost hurts wallets

The rising cost of specialty drugs to treat complex, chronic or life-threatening conditions has the potential to break the pocket books of businesses, consumers, insurance companies and the state, according to Milam Ford of Blue Cross and Blue Shield of Louisiana.

He said everyone will pay for these specialty drugs, whether they take them or not. Because the cost of insurance coverage is a reflection of the price of healthcare services, the high and rising cost of specialty drugs unavoidably puts the pharmacy benefit at risk and adds to premiums for everyone, Ford said.

Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.